JPH0733433B2 - New polymer - Google Patents

New polymer

Info

Publication number
JPH0733433B2
JPH0733433B2 JP5142844A JP14284493A JPH0733433B2 JP H0733433 B2 JPH0733433 B2 JP H0733433B2 JP 5142844 A JP5142844 A JP 5142844A JP 14284493 A JP14284493 A JP 14284493A JP H0733433 B2 JPH0733433 B2 JP H0733433B2
Authority
JP
Japan
Prior art keywords
copolymer
lactic acid
glycolic acid
molecular weight
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP5142844A
Other languages
Japanese (ja)
Other versions
JPH0649185A (en
Inventor
幹晃 田中
泰亮 小川
力 宮川
俊雄 渡辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP59140356A priority Critical patent/JPH0678425B2/en
Application filed by Wako Pure Chemical Industries Ltd, Takeda Chemical Industries Ltd filed Critical Wako Pure Chemical Industries Ltd
Priority to JP5142844A priority patent/JPH0733433B2/en
Publication of JPH0649185A publication Critical patent/JPH0649185A/en
Publication of JPH0733433B2 publication Critical patent/JPH0733433B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、生体吸収性医薬製剤用
基剤として有用な、乳酸とグリコール酸との共重合体
(以下、本発明の共重合体と称することもある。)に関
する。
The present invention relates to a bioabsorbable pharmaceutical preparation.
The present invention relates to a copolymer of lactic acid and glycolic acid useful as a base (hereinafter sometimes referred to as the copolymer of the present invention).

【0002】[0002]

【発明の背景】近年、プラスチック公害を緩和するため
の易分解性高分子として、また、生体吸収性医薬製剤用
高分子としてなど、分解性高分子が少なからず注目され
ている。
BACKGROUND OF THE INVENTION In recent years, degradable polymers have attracted considerable attention as easily degradable polymers for mitigating plastic pollution and as polymers for bioabsorbable pharmaceutical preparations.

【0003】上記の如き目的の為のものとして、特開昭
56-45920号公報に、乳酸とグリコール酸とを強酸性イオ
ン交換樹脂の存在下で重合させる方法が開示されてお
り、それによると、重量平均分子量が約6,000乃至35,00
0の実質的に重合触媒を含有していない重合体が得られ
るとされている。
As one for the above-mentioned purpose, Japanese Patent Laid-Open No.
56-45920 discloses a method of polymerizing lactic acid and glycolic acid in the presence of a strongly acidic ion exchange resin, according to which the weight average molecular weight is about 6,000 to 35,00.
It is said that a polymer having substantially no polymerization catalyst of 0 is obtained.

【0004】しかしながら、上記方法で製造された重合
体は、ゲル浸透クロマトグラフィー法により求めた分子
量分散度が3前後或はそれ以上と大きく、使用に際し、
溶解性、その他の面に於て要因が複雑になり、コントロ
ールに多大の問題があるので、生体吸収性医薬製剤用高
分子として用いる場合などにはあまり好ましいとはいえ
ない。しかもこの方法では、重合触媒として用いられる
強酸性イオン交換樹脂が加熱重縮合反応時に熱によって
劣化し、得られる重合体中に溶け込んで、それが重合体
の着色となって現われる。更にまた、一旦着色した重合
体からそのような着色を除去するのは難しく、完全に除
去するのは実際上不可能である。かかる着色は商品価値
を落とすのみならず、それが不純物に起因するものであ
る以上好ましくない状態であることはいうを俟たない。
However, the polymer produced by the above-mentioned method has a large molecular weight dispersity of about 3 or more as determined by gel permeation chromatography, and therefore, when used,
Since factors such as solubility and other aspects are complicated and there are many problems in control, it is not preferable when used as a polymer for bioabsorbable pharmaceutical preparations. Moreover, in this method, the strongly acidic ion-exchange resin used as the polymerization catalyst is deteriorated by heat during the heat polycondensation reaction and is dissolved in the obtained polymer, which appears as coloring of the polymer. Furthermore, it is difficult to remove such color from once colored polymers and practically impossible to completely remove it. It goes without saying that such coloring not only lowers the commercial value but is also in an unfavorable state because it is caused by impurities.

【0005】[0005]

【発明の目的】かかる状況に鑑み、本発明者らは、乳酸
とグリコール酸との共重合体の有効で且つ上記の如き欠
点のない製造法について鋭意研究を重ねた結果、乳酸及
びグリコール酸又はそれらの低分子の重合物若しくは共
重合物を無触媒で減圧下加熱する重縮合反応に付すこと
により、重量平均分子量が約5,000以上30,00
0以下と大きく、ゲル浸透クロマトグラフィー法による
分散度が約1.5〜2と小さい、且つ重合触媒を全く含
有していない、無色乃至殆ど白色の共重合体が得られる
ことを見出し、これに基づいて更に研究した結果、本発
明を完成した。
SUMMARY OF THE INVENTION In view of the above situation, the inventors of the present invention have conducted earnest studies on a production method of a copolymer of lactic acid and glycolic acid, which is effective and does not have the above-mentioned drawbacks. By subjecting these low molecular weight polymers or copolymers to polycondensation reaction by heating under reduced pressure without a catalyst, the weight average molecular weight is about 5,000 or more and 30,000 or more .
It was found that a colorless or almost white copolymer having a dispersity by gel permeation chromatography as small as 0 or less and a dispersity by the gel permeation chromatography method as small as about 1.5 to 2 and containing no polymerization catalyst at all can be obtained. As a result of further research based on this, the present invention has been completed.

【0006】[0006]

【発明の構成】本発明は、重量平均分子量約5,000以上3
0,000以下で、触媒を全く含まず、ゲル浸透クロマトグ
ラフィー法により求めた分散度が約1.5〜2である乳酸
約50〜95重量%及びグリコール酸約50〜5重量%からな
る、乳酸・グリコール酸共重合体 、である。
The present invention has a weight average molecular weight of about 5,000 or more 3
Lactic acid / glycolic acid consisting of about 50-95% by weight lactic acid and about 50-5% by weight glycolic acid having a dispersity determined by gel permeation chromatography of about 1.5 to 2 at a level of 0,000 or less and containing no catalyst. Is a copolymer.

【0007】[0007]

【0008】また、本発明は、重量平均分子量約5,0
00以上30,000以下で、触媒を全く含まず、ゲル
浸透クロマトグラフィー法により求めた分散度が約1.
5〜2で、乳酸約50〜95重量%及びグリコール酸約
50〜5重量%からなる乳酸・グリコール酸の高分子共
重合体を含んでなる、生体吸収性医薬製剤用基剤、であ
る。
Further, the present invention has a weight average molecular weight of about 5,0
It is from 00 to 30,000 and contains no catalyst, and the dispersity determined by gel permeation chromatography is about 1.
5 to 2, a lactic acid / glycolic acid polymer consisting of about 50 to 95% by weight of lactic acid and about 50 to 5% by weight of glycolic acid.
A bioabsorbable base for a pharmaceutical preparation, comprising a polymer .

【0009】本発明の共重合体を製造するに当り、原料
として用いる乳酸としては通常各種濃度の乳酸水溶液が
任意に選ばれるが、作業性の点からいえば乳酸濃度は高
い方が良く、85%以上が望ましい。また、入手可能なら
ば水溶液としてではなく乳酸そのものを用いた方が良い
ことはいうまでもない。また、グリコール酸としては、
通常、結晶のものがそのまま用いられるが、水溶液とし
て用いても一向に差し支えない。乳酸とグリコール酸と
を結晶等の固体のものを用いる場合には、要すればこれ
らを溶解する溶媒を用いてもかまわない。該溶媒として
は、例えば、水,メタノール,エタノール,アセトンな
どが挙げられる。
In producing the copolymer of the present invention, an aqueous solution of lactic acid having various concentrations is usually arbitrarily selected as the lactic acid used as a raw material. From the viewpoint of workability, the higher the lactic acid concentration is, the better. % Or more is desirable. Needless to say, it is better to use lactic acid itself rather than the aqueous solution if available. Also, as glycolic acid,
Usually, crystals are used as they are, but they can be used as an aqueous solution. When solid lactic acid and glycolic acid such as crystals are used, a solvent that dissolves them may be used if necessary. Examples of the solvent include water, methanol, ethanol, acetone and the like.

【0010】本発明の共重合体を製造するに当り、原料
として用いられる乳酸およびグリコール酸としては、乳
酸の低分子重合物、グリコール酸の低分子重合物、乳酸
とグリコール酸との低分子共重合物でもよい。
Lactic acid and glycolic acid used as raw materials for producing the copolymer of the present invention include low molecular weight polymers of lactic acid, low molecular weight polymers of glycolic acid, and low molecular weight copolymers of lactic acid and glycolic acid. It may be a polymer.

【0011】該低分子重合物としては、たとえば乳酸の
オリゴマー(例、ダイマー,トリマーなど)、グリコー
ル酸のオリゴマー(例、ダイマー,トリマーなど)など
が挙げられる。
Examples of the low molecular weight polymer include lactic acid oligomers (eg, dimers, trimers, etc.) and glycolic acid oligomers (eg, dimers, trimers, etc.).

【0012】また、該低分子重合物あるいは低分子共重
合物としては、乳酸および/またはグリコール酸を触媒
の非存在下に重縮合させて得られたものが挙げられる。
該低分子重合物あるいは低分子共重合物を製造する際の
反応温度及び反応時間は、100〜150℃/350〜30mmHgで
2時間以上、通常は2〜10時間程度、例えば、105℃/3
50mmHgから150℃/30mmHgまで段階的に温度及び減圧度
を高めながら5〜6時間減圧下加熱反応させることによ
り水分を除去すればよい。このようにして、分子量約2,
000〜4,000の低分子重合物あるいは低分子共重合物が容
易に得られる。
Examples of the low molecular weight polymer or low molecular weight copolymer include those obtained by polycondensing lactic acid and / or glycolic acid in the absence of a catalyst.
The reaction temperature and reaction time for producing the low molecular weight polymer or low molecular weight copolymer are 100 to 150 ° C / 350 to 30 mmHg for 2 hours or more, usually about 2 to 10 hours, for example, 105 ° C / 3.
Water may be removed by heating reaction under reduced pressure for 5 to 6 hours while gradually increasing the temperature and the degree of reduced pressure from 50 mmHg to 150 ° C./30 mmHg. In this way, the molecular weight is about 2,
000 to 4,000 low molecular weight polymers or low molecular weight copolymers can be easily obtained.

【0013】また、該低分子重合物あるいは低分子共重
合物としては、無触媒で行なう公知の方法で重縮合して
得られたものでもよい。該公知方法としては、例えば工
業化学雑誌第68巻 983〜986頁(1965年)に記載された
方法、すなわち乳酸とグリコール酸とを常圧下無触媒で
202℃、6時間反応させる方法が挙げられる。また、該
公知方法としては、たとえば、米国特許第2,362,511号
公報に記載された方法、即ち、乳酸とグリコール酸とを
200℃の温度で2時間反応させ、次いで減圧下1/2時間加
熱を続ける方法なども挙げられる。
The low molecular weight polymer or low molecular weight copolymer may be obtained by polycondensation by a known method without catalyst. The known method is, for example, the method described in Industrial Chemistry, Vol. 68, pages 983-986 (1965), that is, lactic acid and glycolic acid under normal pressure without a catalyst.
A method of reacting at 202 ° C. for 6 hours can be mentioned. As the known method, for example, the method described in U.S. Pat.No. 2,362,511, that is, lactic acid and glycolic acid are used.
A method of reacting at a temperature of 200 ° C. for 2 hours and then continuing heating under reduced pressure for 1/2 hour can also be mentioned.

【0014】本発明の共重合体は、乳酸及びグリコール
酸の割合が、乳酸約50〜95重量%及びグリコール酸約50
〜5重量%、好ましくは乳酸約60〜95重量%及びグリコ
ール酸約40〜5重量%、より好ましくは、乳酸約60〜85
重量%及びグリコール酸約40〜15重量%から成る。乳酸
とグリコール酸との特に好ましい比率としては、乳酸約
75±2モル%及びグリコール酸約25±2モル%が挙げら
れる。
The copolymer of the present invention has a ratio of lactic acid and glycolic acid of about 50 to 95% by weight of lactic acid and about 50% of glycolic acid.
-5% by weight, preferably about 60-95% lactic acid and about 40-5% glycolic acid, more preferably about 60-85 lactic acid.
% And about 40-15% by weight glycolic acid. A particularly preferable ratio of lactic acid to glycolic acid is about lactic acid.
75 ± 2 mol% and about 25 ± 2 mol% glycolic acid.

【0015】本発明の共重合体を製造する際の重縮合反
応における加熱温度は、例えば通常約150〜250℃であ
り、好ましくは約150〜200℃である。減圧としては、例
えば通常約30〜1mmHg、好ましくは約10〜1mmHgであ
る。反応時間は、例えば約10時間以上であり、好ましく
は約10〜150時間、更に好ましくは約10〜100時間であ
る。
The heating temperature in the polycondensation reaction for producing the copolymer of the present invention is, for example, usually about 150 to 250 ° C, preferably about 150 to 200 ° C. The reduced pressure is, for example, usually about 30 to 1 mmHg, preferably about 10 to 1 mmHg. The reaction time is, for example, about 10 hours or longer, preferably about 10 to 150 hours, more preferably about 10 to 100 hours.

【0016】乳酸及びグリコール酸を原料物質として用
いる場合の反応条件としては、次のものが好ましい。例
えば、100〜150℃/350〜30mmHgで2時間以上、通常は
2〜10時間程度、例えば、105℃/350mmHgから150℃/3
0mmHgまで段階的に温度及び減圧度を高めながら5〜6
時間減圧下加熱反応させることにより水分を除去した
後、150〜200℃/10〜1mmHgで10時間以上(通常は100
時間ぐらい迄でよい)脱水重縮合反応させればよい。
The following reaction conditions are preferable when lactic acid and glycolic acid are used as raw materials. For example, 100 to 150 ° C / 350 to 30 mmHg for 2 hours or more, usually about 2 to 10 hours, for example, 105 ° C / 350 mmHg to 150 ° C / 3
5-6 while gradually increasing the temperature and the degree of vacuum to 0 mmHg
After removing water by heating reaction under reduced pressure for 10 hours at 150-200 ° C / 10-1mmHg for 10 hours or more (usually 100
The dehydration polycondensation reaction is sufficient.

【0017】また、上記した低分子の重合物或は共重合
物を原料物質として用いる場合の反応条件としては、次
のものが好ましい。即ち、例えば、150〜200℃/10〜1
mmHgで10時間以上(通常は100時間ぐらい迄でよい)脱
水重縮合反応させればよい。
The following reaction conditions are preferable when the above-mentioned low molecular weight polymer or copolymer is used as a raw material. That is, for example, 150 to 200 ° C / 10 to 1
The dehydration polycondensation reaction may be performed for 10 hours or longer (usually about 100 hours) at mmHg.

【0018】反応終了後は、反応液を単に熱時濾過する
か、或は塩化メチレン、ジクロルエタン、クロロホル
ム、アセトン等の適当な溶媒(重合体と同量乃至10倍量
程度使用)に重合体を溶かして濾過する等によりゴミを
除き、前者即ち反応液をそのまま濾過した場合にはそれ
だけで、また後者即ち反応液を溶媒に溶かして濾過した
場合には、用いた溶媒を濃縮留去することにより、目的
の高分子量共重合体を容易に得ることができる。また、
要すれば、濾過した反応液を直接、或は溶媒を用いた場
合には濃縮した濾液を、大量の沈澱剤中に注ぐ等常法に
より分離してもよいし、更に必要であれば再沈澱等によ
り精製すればよい。以下に実験例及び実施例を挙げて本
発明を更に詳細に説明する。
After completion of the reaction, the reaction solution is simply filtered while hot, or the polymer is added to an appropriate solvent such as methylene chloride, dichloroethane, chloroform or acetone (the same amount to about 10 times as much as the polymer is used). By removing the dust by dissolving and filtering, the former, that is, the reaction solution is filtered as it is, and the latter, that is, when the reaction solution is dissolved in the solvent and filtered, the solvent used is concentrated and distilled off. The desired high molecular weight copolymer can be easily obtained. Also,
If necessary, the filtered reaction solution may be separated directly by a conventional method such as pouring the concentrated filtrate into a large amount of a precipitating agent directly when a solvent is used, or reprecipitation if necessary. And the like. Hereinafter, the present invention will be described in more detail with reference to experimental examples and examples.

【0019】[0019]

【実施例】【Example】

実験例1.85%乳酸水溶液 160g(1.5モル)とグリコ
ール酸 38g(0.5モル)とを混合し、窒素気流下100〜1
50℃/350〜30mmHgで段階的に6時間減圧加熱を行ない
留出水を除去した後、175℃/6〜5mmHgで72時間脱水
縮合反応させた。
Experimental example 1. Mixing 160 g (1.5 mol) of 85% lactic acid aqueous solution and 38 g (0.5 mol) of glycolic acid, 100 to 1 under a nitrogen stream.
After stepwise heating under reduced pressure at 50 ° C./350 to 30 mmHg for 6 hours to remove distilled water, dehydration condensation reaction was carried out at 175 ° C./6 to 5 mmHg for 72 hours.

【0020】本法による乳酸とグリコール酸との共重合
体製造に於ける反応時間と到達重量平均分子量との関係
を表1に示す。
Table 1 shows the relationship between the reaction time and the achieved weight average molecular weight in the production of the copolymer of lactic acid and glycolic acid by this method.

【0021】また、比較のために、重合触媒として市販
の強酸性イオン交換樹脂であるダウエックス50W〔ダウ
ケミカル社製(米国),登録商標〕を用いた場合の結果
も併せて表1に示す。
For comparison, Table 1 also shows the results when a commercially available strong acid ion-exchange resin Dowex 50W [Dow Chemical Company (USA), registered trademark] is used as a polymerization catalyst. .

【0022】[0022]

【表1】 *:各反応時間毎に得られた共重合体を、4倍量の塩化
メチレンに溶解し、濾過した後濃縮して溶媒を留去し、
得られた共重合体をJISK8004の2に従い(即
ち、試料約3gを時計ザラにとり、白紙の上において調
べる)試験した。
[Table 1] *: The copolymer obtained at each reaction time is dissolved in 4 volumes of methylene chloride, filtered and concentrated to remove the solvent,
The obtained copolymer was tested according to JIS K8004-2 (that is, about 3 g of a sample was taken with a watch glass and examined on a white paper).

【0023】尚、表中の重量平均分子量及び分散度(重
量平均分子量/数平均分子量)は、分子量既知の標準ポ
リスチレンを用いたゲル浸透クロマトグラフィー法によ
り測定し、求めた。
The weight average molecular weight and the degree of dispersion (weight average molecular weight / number average molecular weight) in the table were determined by gel permeation chromatography using standard polystyrene of known molecular weight.

【0024】表1から明らかなように、本発明に係る製
造法によれば、容易に、重量平均分子量約5,000以上の
高分子量乳酸・グリコール酸共重合体を得ることがで
き、得られた共重合体には着色は観測されず、分子量分
散度も2以下と小さいものが得られる。
As is clear from Table 1, according to the production method of the present invention, a high molecular weight lactic acid / glycolic acid copolymer having a weight average molecular weight of about 5,000 or more can be easily obtained, and the obtained copolymer is obtained. Coloring is not observed in the polymer, and a polymer having a small molecular weight dispersity of 2 or less is obtained.

【0025】上記で得られた本発明の共重合体を重クロ
ロホルム溶液として核磁気共鳴スペクトルで、乳酸とグ
リコール酸との共重合組成を分析した結果を表2に示
す。
The copolymer composition of lactic acid and glycolic acid obtained by analyzing the copolymer of the present invention obtained above in a deuterated chloroform solution by nuclear magnetic resonance spectrum is shown in Table 2.

【0026】[0026]

【表2】 [Table 2]

【0027】実施例1.温度計、コンデンサー、窒素導
入管を備えた四頸フラスコに、85%乳酸水溶液191g及
びグリコール酸 17.5gをとり、窒素気流下、内温及び
内圧をそれぞれ105℃、350mmHgから150℃、30mmHgまで
6時間かけて減圧加熱を行ない、留出水を除去した。引
き続き、減圧度を3mmHgとし、内温175℃で72時間加熱
を行なった。反応液を室温まで冷却して、乳酸とグリコ
ール酸との共重合体として殆ど無色の塊状重合体 140g
を得た。共重合体の重量平均分子量及び分散度は、22,0
00及び1.70であった。尚、これら重量平均分子量及び分
散度は、ゲル浸透ゲルクロマトグラフィー法により求め
た(以下、同じ。)。更に得られた共重合体を重クロロ
ホルム溶液として核磁気共鳴スペクトルで分析した結
果、共重合体中の乳酸とグリコール酸との組成は、89モ
ル%:11モル%(90.9重量%:9.1重量%)であった。
Example 1. In a four-necked flask equipped with a thermometer, a condenser, and a nitrogen introduction tube, take 191 g of 85% lactic acid aqueous solution and 17.5 g of glycolic acid. Distilled water was removed by heating under reduced pressure over time. Subsequently, the degree of vacuum was set to 3 mmHg, and heating was performed at an internal temperature of 175 ° C. for 72 hours. The reaction solution was cooled to room temperature and 140 g of an almost colorless bulk polymer as a copolymer of lactic acid and glycolic acid.
Got The weight average molecular weight and dispersity of the copolymer are 22,0
It was 00 and 1.70. The weight average molecular weight and the dispersity were determined by the gel permeation gel chromatography method (hereinafter the same). Further, the obtained copolymer was analyzed by nuclear magnetic resonance spectrum as a heavy chloroform solution, and the composition of lactic acid and glycolic acid in the copolymer was 89 mol%: 11 mol% (90.9 wt%: 9.1 wt% )Met.

【0028】比較例1.85%乳酸水溶液 191g及びグリ
コール酸 17.5gに、市販の強酸性イオン交換樹脂であ
るダウエックス50W(架橋ポリスチレン樹脂) 6.8gを
加え、実施例1と同様に、窒素気流下、内温及び内圧を
それぞれ105℃、350mmHgから150℃、30mmHgまで6時間
かけて減圧加熱を行ない、留出水を除去した。更にダウ
エックス50W 6.8gを追加して、減圧度を3mmHgとし、
内温175℃で72時間加熱を行なった。反応液を熱時濾過
してダウエックス50Wを除き、濾液を室温まで冷却し
て、重量平均分子量23,700、分散度2.88の塊状重合体 1
31gを得たが、重合体は褐色に着色していた。尚、得ら
れた共重合体中の乳酸とグリコール酸との組成は、88.5
モル%:11.5モル%(90.5重量%:9.5重量%)であっ
た。
Comparative Example 1. To 191 g of 85% aqueous lactic acid solution and 17.5 g of glycolic acid, 6.8 g of Dowex 50W (crosslinked polystyrene resin), which is a commercially available strong acidic ion exchange resin, was added, and a nitrogen stream was prepared in the same manner as in Example 1. The inner temperature and the inner pressure were reduced from 105 ° C. and 350 mmHg to 150 ° C. and 30 mmHg, respectively, under reduced pressure heating for 6 hours to remove distilled water. Furthermore, 6.8g of Dowex 50W is added to reduce the pressure to 3mmHg,
Heating was performed at an internal temperature of 175 ° C for 72 hours. The reaction solution was filtered while hot to remove Dowex 50W, and the filtrate was cooled to room temperature to obtain a bulk polymer having a weight average molecular weight of 23,700 and a dispersity of 2.88.
Although 31 g was obtained, the polymer was colored brown. The composition of lactic acid and glycolic acid in the obtained copolymer was 88.5.
It was mol%: 11.5 mol% (90.5 wt%: 9.5 wt%).

【0029】実施例2.実施例1と同じ重合装置に、85
%乳酸水溶液 106g及びグリコール酸 76gをとり、窒
素気流下、内温及び内圧をそれぞれ105℃、350mmHgから
150℃、30mmHgまで3時間かけて減圧加熱を行ない、留
出水を除去した。引き続き減圧度を3mmHgとし、内温18
0℃で36時間加熱を行なった。反応液を室温まで冷却し
て、乳酸とグリコール酸との共重合体として殆ど無色の
塊状重合体 124gを得た。共重合体の重量平均分子量及
び分散度は、15,300及び1.73であった。更に得られた共
重合体を重クロロホルム溶液として核磁気共鳴スペクト
ルで分析した結果、共重合体中の乳酸とグリコール酸と
の組成は、50.5モル%:49.5モル%(55.9重量%:44.1
重量%)であった。
Example 2. In the same polymerization apparatus as in Example 1, 85
% Aqueous lactic acid solution (106 g) and glycolic acid (76 g) are used, and the internal temperature and internal pressure are respectively from 105 ℃ and 350mmHg under nitrogen stream.
Distilled water was removed by heating under reduced pressure to 150 ° C. and 30 mmHg for 3 hours. Continue to reduce the pressure to 3 mmHg and set the internal temperature to 18
Heated at 0 ° C. for 36 hours. The reaction solution was cooled to room temperature to obtain 124 g of an almost colorless bulk polymer as a copolymer of lactic acid and glycolic acid. The weight average molecular weight and dispersity of the copolymer were 15,300 and 1.73. As a result of nuclear magnetic resonance spectrum analysis of the obtained copolymer as a deuterated chloroform solution, the composition of lactic acid and glycolic acid in the copolymer was 50.5 mol%: 49.5 mol% (55.9 wt%: 44.1
% By weight).

【0030】実施例3.93%乳酸水溶液 146g及びグリ
コール酸 38gを用い、202℃で6時間の加熱反応を行な
い、重量平均分子量2,700、共重合組成 乳酸:グリコー
ル酸=75モル%:25モル%の共重合物を得た。このよう
にして得られた共重合物 100gを用いて、5mmHg、175
℃で70時間、減圧・加熱反応を行なった。反応液を室温
まで冷却して殆ど無色の塊状共重合体 92gを得た。共
重合体の重量平均分子量及び分散度はそれぞれ17,700及
び1.85であり、更に乳酸とグリコール酸の共重合組成は
75.5モル%:24.5モル%(79.3重量%:20.7重量%)で
あった。
Example 3 Using 146 g of a 93% aqueous lactic acid solution and 38 g of glycolic acid, a heating reaction was carried out at 202 ° C. for 6 hours to give a weight average molecular weight of 2,700 and a copolymer composition of lactic acid: glycolic acid = 75 mol%: 25 mol% To obtain a copolymer of Using 100 g of the copolymer thus obtained, 5 mmHg, 175
The reaction was carried out under reduced pressure and heating at 70 ° C. for 70 hours. The reaction solution was cooled to room temperature to obtain 92 g of an almost colorless block copolymer. The weight average molecular weight and dispersity of the copolymer are 17,700 and 1.85, respectively, and the copolymer composition of lactic acid and glycolic acid is
It was 75.5 mol%: 24.5 mol% (79.3 wt%: 20.7 wt%).

【0031】実施例4.実施例1と同じ重合装置に、乳
酸2量体(乳酸ラクテート) 97g及びグリコール酸2
量体(グリコール酸グリコレート) 54gを取り、窒素
気流下で直接5mmHg、180℃の減圧・加熱反応を48時間
行なった。反応液を室温まで冷却し、乳酸とグリコール
酸との共重合体として殆ど白色の塊状共重合体 105gを
得た。共重合体の重量平均分子量及び分散度はそれぞれ
18,300及び1.76であり、更に乳酸とグリコール酸との共
重合組成は60モル%:40モル%(65.1重量%:34.9重量
%)であった。
Example 4. In the same polymerization apparatus as in Example 1, 97 g of lactic acid dimer (lactic acid lactate) and 2 parts of glycolic acid were added.
54 g of a monomer (glycolic acid glycolate) was taken and directly subjected to a reduced pressure / heating reaction at 5 mmHg and 180 ° C. for 48 hours under a nitrogen stream. The reaction solution was cooled to room temperature to obtain 105 g of a substantially white block copolymer as a copolymer of lactic acid and glycolic acid. The weight average molecular weight and dispersity of the copolymer are
18,300 and 1.76, and the copolymer composition of lactic acid and glycolic acid was 60 mol%: 40 mol% (65.1 wt%: 34.9 wt%).

【0032】実施例5.実施例1と同様の重合装置に、
89%乳酸水溶液 3337g(33モル)及びグリコール酸 83
6g(11モル)をとり、窒素気流下、内温及び内圧をそ
れぞれ100℃、350mmHgから150℃、30mmHgまで6時間か
けて減圧加熱を行ない、留出水を除去した。引き続き減
圧度を5mmHgとし、内温175℃で50時間加熱を行なっ
た。反応液を室温まで冷却して、乳酸とグリコール酸と
の共重合体として殆ど無色の塊状重合体 2400gを得
た。共重合体の重量平均分子量及び分散度はそれぞれ1
4,400及び1.66であり、更に乳酸とグリコール酸との共
重合組成は、75モル%:25モル%(78.8重量%:21.2重
量%)であった。
Example 5. In the same polymerization apparatus as in Example 1,
89% lactic acid aqueous solution 3337 g (33 mol) and glycolic acid 83
6 g (11 mol) was taken, and the internal temperature and internal pressure were heated under reduced pressure from 100 ° C. and 350 mmHg to 150 ° C. and 30 mmHg for 6 hours to remove the distilled water. Subsequently, the degree of vacuum was set to 5 mmHg, and heating was performed at an internal temperature of 175 ° C. for 50 hours. The reaction solution was cooled to room temperature to obtain 2400 g of an almost colorless bulk polymer as a copolymer of lactic acid and glycolic acid. The weight average molecular weight and dispersity of the copolymer are each 1
4,400 and 1.66, and the copolymer composition of lactic acid and glycolic acid was 75 mol%: 25 mol% (78.8 wt%: 21.2 wt%).

【0033】[0033]

【発明の効果】本発明の共重合体は、重量平均分子量約
5,000〜30,000の高分子量であり、ゲル浸透クロマトグ
ラフィー法による分散度が約1.5乃至2と小さい。本発
明の共重合体は、重合触媒を全く用いずに重縮合するた
め、得られた共重合体は重合触媒を全く含んでおらず、
従って外観着色は殆ど観測されない。
The copolymer of the present invention has a weight average molecular weight of about
It has a high molecular weight of 5,000 to 30,000 and a small degree of dispersion by gel permeation chromatography of about 1.5 to 2. The copolymer of the present invention undergoes polycondensation without using any polymerization catalyst, so that the obtained copolymer does not contain any polymerization catalyst,
Therefore, almost no external coloration is observed.

【0034】本発明の共重合体は、主に医薬品の製剤基
剤として利用できる。例えばステロイドホルモン類、ペ
プチドホルモン類、或は制ガン剤等を含有させ、埋込み
型若しくはマイクロカプセル型徐放性製剤として、或は
制ガン剤を含有した微粒を造り塞栓治療剤として有利に
利用できる。
The copolymer of the present invention can be mainly used as a pharmaceutical preparation base. For example, steroid hormones, peptide hormones, or carcinostatic agents, etc. are contained, and they can be advantageously used as implantable or microcapsule sustained-release preparations, or fine particles containing carcinostatic agents are prepared and embolization therapeutic agents.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭56−45920(JP,A) ─────────────────────────────────────────────────── ─── Continuation of the front page (56) References JP-A-56-45920 (JP, A)

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】重量平均分子量約5,000以上30,0
00以下で、触媒を全く含まず、ゲル浸透クロマトグラ
フィー法により求めた分散度が約1.5〜2である、乳
酸約50〜95重量%及びグリコール酸約50〜5重量
%からなる乳酸・グリコール酸共重合体。
1. A weight average molecular weight of about 5,000 or more 30,0.
Lactic acid consisting of about 50 to 95% by weight of lactic acid and about 50 to 5% by weight of glycolic acid having a dispersity determined by a gel permeation chromatography method of about 1.5 to 2 and containing no catalyst. Glycolic acid copolymer.
【請求項2】重量平均分子量約5,000以上30,0
00以下で、触媒を全く含まず、ゲル浸透クロマトグラ
フィー法により求めた分散度が約1.5〜2で、乳酸約
50〜95重量%及びグリコール酸約50〜5重量%か
らなる乳酸・グリコール酸の高分子共重合体を含んでな
る、生体吸収性医薬製剤用基剤
2. A weight average molecular weight of about 5,000 or more 30,0.
A gel permeation chromatograph of less than 00, containing no catalyst
The dispersity determined by the Fee method is about 1.5 to 2,
50-95 wt% and glycolic acid about 50-5 wt%
Lactic acid / glycolic acid
A base for bioabsorbable pharmaceutical preparations .
JP5142844A 1984-07-06 1993-05-21 New polymer Expired - Lifetime JPH0733433B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP59140356A JPH0678425B2 (en) 1984-07-06 1984-07-06 New polymer manufacturing method
JP5142844A JPH0733433B2 (en) 1984-07-06 1993-05-21 New polymer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59140356A JPH0678425B2 (en) 1984-07-06 1984-07-06 New polymer manufacturing method
JP5142844A JPH0733433B2 (en) 1984-07-06 1993-05-21 New polymer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP59140356A Division JPH0678425B2 (en) 1984-07-06 1984-07-06 New polymer manufacturing method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP7844298A Division JP3168263B2 (en) 1984-07-06 1998-03-11 Novel polymer and drug using the same

Publications (2)

Publication Number Publication Date
JPH0649185A JPH0649185A (en) 1994-02-22
JPH0733433B2 true JPH0733433B2 (en) 1995-04-12

Family

ID=26472898

Family Applications (2)

Application Number Title Priority Date Filing Date
JP59140356A Expired - Lifetime JPH0678425B2 (en) 1984-07-06 1984-07-06 New polymer manufacturing method
JP5142844A Expired - Lifetime JPH0733433B2 (en) 1984-07-06 1993-05-21 New polymer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP59140356A Expired - Lifetime JPH0678425B2 (en) 1984-07-06 1984-07-06 New polymer manufacturing method

Country Status (1)

Country Link
JP (2) JPH0678425B2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5948204A (en) * 1982-09-13 1984-03-19 Bridgestone Corp Pneumatic radial tire with reduced rolling resistance
JPS5975810A (en) * 1982-10-26 1984-04-28 Bridgestone Corp Improved pneumatic radial tire
JPH0678425B2 (en) * 1984-07-06 1994-10-05 和光純薬工業株式会社 New polymer manufacturing method
JPS63219402A (en) * 1987-05-16 1988-09-13 Bridgestone Corp Pneumatic radial tire with reduced rolling resistance
NO302481B1 (en) 1990-10-16 1998-03-09 Takeda Chemical Industries Ltd Polymer for an extended release preparation, as well as an extended release preparation
EP0582459B1 (en) 1992-08-07 1998-01-07 Takeda Chemical Industries, Ltd. Production of microcapsules of water-soluble drugs
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
WO1995028432A1 (en) * 1994-04-15 1995-10-26 Kyowa Hakko Kogyo Co., Ltd. Process for producing poly(hydroxy carboxylic acid)
US5646238A (en) * 1994-07-27 1997-07-08 Mitsui Toatsu Chemicals, Inc. Preparation process of polyhydroxycarboxylic acid
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5770683A (en) * 1994-11-02 1998-06-23 Mitsui Toatsu Chemicals, Inc. Preparation process of polyhydroxycarboxylic acid
WO1997008220A1 (en) * 1995-08-29 1997-03-06 Kyowa Hakko Kogyo Co., Ltd. Process for producing polyhydroxy carboxylic acid
AU1732897A (en) * 1996-02-23 1997-09-10 Kyowa Hakko Kogyo Co. Ltd. Process for the preparation of polyhydroxycarboxylic acid
CA2430934C (en) 2000-12-01 2011-06-21 Takeda Chemical Industries, Ltd. A method of producing sustained-release preparations of a bioactive substance using high-pressure gas
TW200526267A (en) 2001-06-29 2005-08-16 Takeda Chemical Industries Ltd Controlled release composition and method of producing the same
TWI225416B (en) 2001-06-29 2004-12-21 Takeda Chemical Industries Ltd Sustained-release composition and process for producing the same
US7314636B2 (en) * 2001-06-29 2008-01-01 Medgraft Microtech, Inc. Biodegradable injectable implants containing glycolic acid
JP2003192773A (en) 2001-12-26 2003-07-09 Mitsui Chemicals Inc Bioabsorptive polyhydroxy carboxylic acid and its production method
US7838494B2 (en) 2004-03-09 2010-11-23 Tohoku Technoarch Co., Ltd. Differentiation- or regeneration-inducing agent for alveoli
ATE382337T1 (en) 2005-04-28 2008-01-15 Nipro Corp BIOABSORBABLE PHARMACEUTICAL COMPOSITION CONTAINING A PLGA COPOLYMER
JP5051725B2 (en) 2006-04-20 2012-10-17 国立大学法人大阪大学 Therapeutic agent or disease inhibitor for polyglutamine disease
US8003607B2 (en) 2006-04-20 2011-08-23 Kringle Pharma Inc. HGF precursor protein variant and active protein thereof
MX2009006653A (en) 2006-12-18 2009-07-02 Takeda Pharmaceutical Sustained-release composition and method for producing the same.
WO2008105088A1 (en) 2007-02-28 2008-09-04 Keio University Agent for treating spinal cord injury
CN102161752B (en) * 2011-03-14 2013-02-27 南京大学 Process method for synthesizing medical biodegradable polylactic acid by polycondensation of lactic acid in presence of creatinine catalyst

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
JPS5996123A (en) * 1982-11-25 1984-06-02 Showa Highpolymer Co Ltd Production of high-molecular weight polylactide
JPH0678425B2 (en) * 1984-07-06 1994-10-05 和光純薬工業株式会社 New polymer manufacturing method

Also Published As

Publication number Publication date
JPS6128521A (en) 1986-02-08
JPH0678425B2 (en) 1994-10-05
JPH0649185A (en) 1994-02-22

Similar Documents

Publication Publication Date Title
JPH0733433B2 (en) New polymer
EP0172636B1 (en) Method for producing a polymer or copolymer of lactic acid and/or glycolic acid
EP0299730B1 (en) Process of preparing dl-lactic acid-glycolic acid-copolymer
DE69838731T2 (en) POLYANHYDRIDE WITH THERAPEUTICALLY APPLICABLE ABBAUPRODUCTS
FI96425C (en) Method for the preparation of new heparin derivatives
JPH08169818A (en) Sustained release microcapsule for injection
HU188657B (en) Process for the preparation of anticoagulant mycopolysaccharides
JPS63503067A (en) Method for obtaining chemically defined and reproducible polydeoxyribonucleotides
US5068269A (en) Cellulosic membranes
EP0849252A1 (en) Purification process of lactic acid
JP3168263B2 (en) Novel polymer and drug using the same
TWI672146B (en) New chemically-modified heparins and processes for their production
JPH0610252B2 (en) Polymer manufacturing method
EP3635029B1 (en) Synthesis of tyrosine derived polyarylates
JPS6397633A (en) Novel chitosan particle
JPH0940766A (en) Method for removing catalyst from lactic acid polymer
US3839317A (en) Digoxin complexes
CN101362746A (en) Separation method of argatroban single stereoisomers and polymorph
US7550628B2 (en) Process for preparing phenolic acid salts of gabapentin
JP3994210B2 (en) Purification method of ion exchange resin
JPH03170435A (en) High-molecular electrolytic complex for treating and preventing virus-caused diseases
JP3008374B2 (en) Method for preventing coloration of dihydroxydiphenylmethane
BRPI0621193B1 (en) method for making a polyalkylene glycol composition and polyalkylene glycol composition
CN115707697A (en) Purification method of crude glycolide and obtained glycolide
EP0498560B1 (en) Synthesis of poly(vinyl phosphonic acid)

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 19980113

EXPY Cancellation because of completion of term